Dr. Martens (DOCS)

Sector:

Personal Goods

Index:

FTSE 250

74.70p
   
  • Change Today:
    -0.70p
  • 52 Week High: 83.80p
  • 52 Week Low: 47.52p
  • Currency: UK Pounds
  • Shares Issued: 966.37m
  • Volume: 331,279
  • Market Cap: £721.88m
  • Beta: 0.03

Growth Ratings

EPS Growth shows the relative growth of a company's earnings over the last year.

The rise in total monies receivable for goods / services sold before expenses.

1yr EPS Growth
92.49% below the market average92.49% below the market average92.49% below the market average92.49% below the market average92.49% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
1yr Revenue Growth
62.94% below the market average62.94% below the market average62.94% below the market average62.94% below the market average62.94% below the market average
25% below the sector average25% below the sector average25% below the sector average25% below the sector average25% below the sector average

Income Ratings

The percentage of the share price that a company pays out as dividends over a year.

The percentage change from the previous year in the dividend paid on each share.

Dividend Yield
3.93% below the market average3.93% below the market average3.93% below the market average3.93% below the market average3.93% below the market average
33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average
1yr DPS Growth Not Available

Valuation Ratings

The share price as a ratio of revenue per share.

The share price as a ratio of net asset value.

Price Sales Ratio
41.18% below the market average41.18% below the market average41.18% below the market average41.18% below the market average41.18% below the market average
75.00% above the sector average75.00% above the sector average75.00% above the sector average75.00% above the sector average75.00% above the sector average
Price Book Ratio
39.73% below the market average39.73% below the market average39.73% below the market average39.73% below the market average39.73% below the market average
25% below the sector average25% below the sector average25% below the sector average25% below the sector average25% below the sector average

Performance Ratings

In percentage total change in share price over 30 days.

In percentage total change in share price over 3 months.

Price Chg 30d
47.98% below the market average47.98% below the market average47.98% below the market average47.98% below the market average47.98% below the market average
Sector averageSector averageSector averageSector averageSector average
Price Chg 3m
69.08% above the market average69.08% above the market average69.08% above the market average69.08% above the market average69.08% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average

Technical Ratings

The Relative Strength Index measures a share price relative to itself and its recent history.

Momentum is an oscillator that measures the rate of price change.

RSI
34.96% below the market average34.96% below the market average34.96% below the market average34.96% below the market average34.96% below the market average
11.11% below the sector average11.11% below the sector average11.11% below the sector average11.11% below the sector average11.11% below the sector average
Momentum 20
52.11% below the market average52.11% below the market average52.11% below the market average52.11% below the market average52.11% below the market average
33.33% below the sector average33.33% below the sector average33.33% below the sector average33.33% below the sector average33.33% below the sector average

Management Ratings

Operating Margin is profit as a percentage of sales.

Return on capital employed measures the return from invested and borrowed capital.

Operating Margin
17.68% below the market average17.68% below the market average17.68% below the market average17.68% below the market average17.68% below the market average
33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average
ROCE
21.03% below the market average21.03% below the market average21.03% below the market average21.03% below the market average21.03% below the market average
50% below the sector average50% below the sector average50% below the sector average50% below the sector average50% below the sector average

Profitability Ratings

Earnings per share, the company's profitability expressed on a per share basis.

Analysts' estimates of future EPS for the next 2 years.

EPS
2.72% below the market average2.72% below the market average2.72% below the market average2.72% below the market average2.72% below the market average
33.33% below the sector average33.33% below the sector average33.33% below the sector average33.33% below the sector average33.33% below the sector average
Forecast EPS Not Available

Profit/Loss Ratings

Monies produced from sales of goods and services after trade discounts, VAT, etc.

Operating Profit is the profit after deducting operating costs from gross profits.

Turnover
65.59% above the market average65.59% above the market average65.59% above the market average65.59% above the market average65.59% above the market average
11.11% above the sector average11.11% above the sector average11.11% above the sector average11.11% above the sector average11.11% above the sector average
Operating Profit Loss
54.74% above the market average54.74% above the market average54.74% above the market average54.74% above the market average54.74% above the market average
55.56% above the sector average55.56% above the sector average55.56% above the sector average55.56% above the sector average55.56% above the sector average

Balance Sheet Ratings

The difference between current assets and current liabilities.

A current asset representing the company's financial liquidity.

Assets
67.09% above the market average67.09% above the market average67.09% above the market average67.09% above the market average67.09% above the market average
11.11% above the sector average11.11% above the sector average11.11% above the sector average11.11% above the sector average11.11% above the sector average
Cash
74.25% above the market average74.25% above the market average74.25% above the market average74.25% above the market average74.25% above the market average
33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average

Director Deal Ratings

The cumulative amount of stocks sold by company directors over 1 year

The cumulative amount of stocks bought by company directors over 1 year

Sells 1y
65.91% below the market average65.91% below the market average65.91% below the market average65.91% below the market average65.91% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
Buys 1y
18.16% above the market average18.16% above the market average18.16% above the market average18.16% above the market average18.16% above the market average
Sector averageSector averageSector averageSector averageSector average

Broker Ratings

The percentage of stockbrokers that rate the company as a Buy

The percentage of stockbrokers that rate the company as a Hold

Brokers Percent Buy Not Available
Brokers Percent Neutral Not Available

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Dr. Martens Market Data

Currency UK Pounds
Share Price 74.70p
Change Today -0.70p
% Change -0.93 %
52 Week High 83.80p
52 Week Low 47.52p
Volume 331,279
Shares Issued 966.37m
Market Cap £721.88m
Beta 0.03

Dr. Martens Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
20.63% below the market average20.63% below the market average20.63% below the market average20.63% below the market average20.63% below the market average
77.78% below the sector average77.78% below the sector average77.78% below the sector average77.78% below the sector average77.78% below the sector average
Price Trend
9.6% below the market average9.6% below the market average9.6% below the market average9.6% below the market average9.6% below the market average
33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average
Income
36.41% below the market average36.41% below the market average36.41% below the market average36.41% below the market average36.41% below the market average
Sector averageSector averageSector averageSector averageSector average
Growth
99.53% below the market average99.53% below the market average99.53% below the market average99.53% below the market average99.53% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average

Dr. Martens Dividends

  Latest Previous
  Final Interim
Ex-Div 28-Aug-25 06-Mar-25
Paid 08-Oct-25 08-Apr-25
Amount 1.70p 0.85p

Trades for 15-Aug-2025

Time Volume / Share Price
17:02 13,903 @ 74.69p
16:35 196,802 @ 74.70p
16:35 1 @ 74.70p
16:35 722 @ 74.70p
16:35 782 @ 74.70p

Dr. Martens Key Personnel

Chair Paul Mason
CEO Ije Nwokori
CFO Giles Wilson

Top of Page